RPS6KB1 and hepatocellular carcinoma: Rapamycin treatment in HCC cell lines reduced p70 S6K phosphorylation and significantly inhibited the HCC proliferation, suggesting a strong association between aberrant mTOR activity and HCC progression [75,82].